News Image

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

Provided By GlobeNewswire

Last update: Mar 25, 2025

Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) infections

Read more at globenewswire.com

ELUTIA INC

NASDAQ:ELUT (11/26/2025, 8:00:01 PM)

After market: 0.6312 -0.04 (-6.21%)

0.673

+0.05 (+8.55%)



Find more stocks in the Stock Screener

Follow ChartMill for more